Nutrients,
Journal Year:
2023,
Volume and Issue:
15(17), P. 3802 - 3802
Published: Aug. 30, 2023
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
is
the
causative
agent
of
disease
2019
(COVID-19).
COVID-19
now
recognized
as
a
multiorgan
with
broad
spectrum
manifestations.
A
substantial
proportion
individuals
who
have
recovered
from
are
experiencing
persistent,
prolonged,
and
often
incapacitating
sequelae,
collectively
referred
to
long
COVID.
To
date,
definitive
diagnostic
criteria
for
COVID
diagnosis
remain
elusive.
An
emerging
public
health
threat
neuropsychiatric
COVID,
encompassing
range
manifestations,
such
sleep
disturbance,
anxiety,
depression,
brain
fog,
fatigue.
Although
precise
mechanisms
underlying
complications
presently
not
fully
elucidated,
neural
cytolytic
effects,
neuroinflammation,
cerebral
microvascular
compromise,
breakdown
blood–brain
barrier
(BBB),
thrombosis,
hypoxia,
neurotransmitter
dysregulation,
provoked
neurodegeneration
pathophysiologically
linked
long-term
consequences,
in
addition
systemic
hyperinflammation
maladaptation
renin–angiotensin–aldosterone
system.
Vitamin
D,
fat-soluble
secosteroid,
potent
immunomodulatory
hormone
potential
beneficial
effects
on
anti-inflammatory
responses,
neuroprotection,
monoamine
neurotransmission,
BBB
integrity,
vasculometabolic
functions,
gut
microbiota,
telomere
stability
different
phases
SARS-CoV-2
infection,
acting
through
both
genomic
nongenomic
pathways.
Here,
we
provide
an
up-to-date
review
pathophysiology
plausible
neurological
contributions
vitamin
D
mitigating
Cells,
Journal Year:
2023,
Volume and Issue:
12(5), P. 688 - 688
Published: Feb. 22, 2023
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
causes
disease
2019
(COVID-19).
About
45%
of
COVID-19
patients
experience
several
symptoms
a
few
months
after
the
initial
infection
and
develop
post-acute
sequelae
SARS-CoV-2
(PASC),
referred
to
as
“Long-COVID,”
characterized
by
persistent
physical
mental
fatigue.
However,
exact
pathogenetic
mechanisms
affecting
brain
are
still
not
well-understood.
There
is
increasing
evidence
neurovascular
inflammation
in
brain.
precise
role
neuroinflammatory
response
that
contributes
severity
long
COVID
pathogenesis
clearly
understood.
Here,
we
review
reports
spike
protein
can
cause
blood–brain
barrier
(BBB)
dysfunction
damage
neurons
either
directly,
or
via
activation
mast
cells
microglia
release
various
molecules.
Moreover,
provide
recent
novel
flavanol
eriodictyol
particularly
suited
for
development
an
effective
treatment
alone
together
with
oleuropein
sulforaphane
(ViralProtek®),
all
which
have
potent
anti-viral
anti-inflammatory
actions.
Neurology International,
Journal Year:
2023,
Volume and Issue:
15(3), P. 821 - 841
Published: July 6, 2023
SARS-CoV-2,
a
single-stranded
RNA
coronavirus,
causes
an
illness
known
as
coronavirus
disease
2019
(COVID-19).
Long-term
complications
are
increasing
issue
in
patients
who
have
been
infected
with
COVID-19
and
may
be
result
of
viral-associated
systemic
central
nervous
system
inflammation
or
arise
from
virus-induced
hypercoagulable
state.
incite
changes
brain
function
wide
range
lingering
symptoms.
Patients
often
experience
fatigue
note
fog,
sensorimotor
symptoms,
sleep
disturbances.
Prolonged
neurological
neuropsychiatric
symptoms
prevalent
can
interfere
substantially
everyday
life,
leading
to
massive
public
health
concern.
The
mechanistic
pathways
by
which
SARS-CoV-2
infection
sequelae
important
subject
ongoing
research.
Inflammation-
induced
blood-brain
barrier
permeability
viral
neuro-invasion
direct
nerve
damage
involved.
Though
the
mechanisms
uncertain,
resulting
documented
numerous
patient
reports
studies.
This
review
examines
constellation
spectrum
seen
long
COVID
incorporates
information
on
prevalence
these
contributing
factors,
typical
course.
Although
treatment
options
generally
lacking,
potential
therapeutic
approaches
for
alleviating
improving
quality
life
explored.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: March 4, 2024
The
coronavirus
disease
2019
(COVID-19)
pandemic
caused
by
SARS-CoV-2
has
been
defined
as
the
greatest
global
health
and
socioeconomic
crisis
of
modern
times.
While
most
people
recover
after
being
infected
with
virus,
a
significant
proportion
them
continue
to
experience
issues
weeks,
months
even
years
acute
infection
SARS-CoV-2.
This
persistence
clinical
symptoms
in
individuals
for
at
least
three
onset
or
emergence
new
lasting
more
than
two
months,
without
any
other
explanation
alternative
diagnosis
have
named
long
COVID,
long-haul
post-COVID-19
conditions,
chronic
post-acute
sequelae
(PASC).
Long
COVID
characterized
constellation
disorders
that
vary
widely
their
manifestations.
Further,
mechanisms
underlying
are
not
fully
understood,
which
hamper
efficient
treatment
options.
review
describes
predictors
common
related
COVID's
effects
on
central
peripheral
nervous
system
organs
tissues.
Furthermore,
transcriptional
markers,
molecular
signaling
pathways
risk
factors
such
sex,
age,
pre-existing
condition,
hospitalization
during
phase
COVID-19,
vaccination,
lifestyle
presented.
Finally,
recommendations
patient
rehabilitation
management,
well
therapeutical
approaches
discussed.
Understanding
complexity
this
disease,
its
across
multiple
organ
systems
overlapping
pathologies
possible
paramount
developing
diagnostic
tools
treatments.
Psychiatry and Clinical Neurosciences,
Journal Year:
2022,
Volume and Issue:
77(2), P. 72 - 83
Published: Sept. 23, 2022
The
novel
coronavirus
disease
19
(COVID‐19),
caused
by
severe
acute
respiratory
syndrome
2
(SARS‐CoV‐2),
can
have
two
phases:
(generally
4
weeks
after
onset)
and
chronic
(>4
onset).
Both
phases
include
a
wide
variety
of
signs
symptoms
including
neurological
psychiatric
symptoms.
that
are
considered
sequelae
COVID‐19
termed
post‐COVID
condition,
long
COVID‐19,
post‐acute
SARS‐CoV‐2
infection
(PASC).
PASC
fatigue,
dyspnea,
palpitation,
dysosmia,
subfever,
hypertension,
alopecia,
sleep
problems,
loss
concentration,
amnesia,
numbness,
pain,
gastrointestinal
symptoms,
depression,
anxiety.
Because
the
specific
pathophysiology
has
not
yet
been
clarified,
there
no
definite
criteria
hence
World
Health
Organization's
definition
is
quite
broad.
Consequently,
it
difficult
to
correctly
diagnose
PASC.
Approximately
50%
patients
may
show
at
least
one
symptom
up
12
months
infection;
however,
exact
prevalence
determined.
Despite
extensive
research
in
progress
worldwide,
currently
clear
diagnostic
methodologies
or
treatments
for
In
this
review,
we
discuss
available
information
on
highlight
infection.
Furthermore,
provide
clinical
suggestions
diagnosing
caring
with
based
our
outpatient
clinic
experience.
Journal of Neural Transmission,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Jan. 23, 2024
Abstract
Fascinatingly,
an
abundance
of
recent
studies
has
subscribed
to
the
importance
cytotoxic
immune
mechanisms
that
appear
increase
risk/trigger
for
many
progressive
neurodegenerative
disorders,
including
Parkinson’s
disease
(PD),
Alzheimer’s
(AD),
amyotrophic
lateral
sclerosis,
and
multiple
sclerosis.
Events
associated
with
neuroinflammatory
cascades,
such
as
ageing,
immunologic
dysfunction,
eventually
disruption
blood–brain
barrier
“cytokine
storm”,
be
orchestrated
mainly
through
activation
microglial
cells
communication
neurons.
The
inflammatory
processes
prompt
cellular
protein
dyshomeostasis.
share
a
common
feature
marked
by
characteristic
pathological
hallmarks
abnormal
neuronal
accumulation.
These
Lewy
bodies
contain
misfolded
α-synuclein
aggregates
in
PD
or
case
AD,
they
are
Aβ
deposits
tau-containing
neurofibrillary
tangles.
Subsequently,
these
further
elicit
neurotoxic
events
which
contribute
onset
neurodegeneration
its
progression
aggravation
neuroinflammation.
However,
there
is
caveat
exclusively
linking
neuroinflammation
neurodegeneration,
since
it’s
highly
unlikely
dysregulation
only
factor
contributes
manifestation
disorders.
It
unquestionably
complex
interaction
other
factors
genetics,
age,
environment.
This
endorses
“multiple
hit
hypothesis”.
Consequently,
if
host
genetic
susceptibility
coupled
age-related
weakened
system,
this
makes
them
more
susceptible
virus/bacteria-related
infection.
may
trigger
chronic
leading
dyshomeostasis
accumulation,
finally,
lead
destruction.
Here,
we
differentiate
“neuroinflammation”
“inflammation”
regard
involvement
barrier,
seems
intact
but
defect
inflammation.
There
neuroinflammation-inflammation
continuum
virus-induced
brain
affection.
Therefore,
propose
staging
process,
might
developed
adding
blood-
CSF
parameters,
their
stage-dependent
composition
severeness
grade.
If
so,
suitable
optimise
therapeutic
strategies
fight
beginning
avoid
inflammation
at
all.
Journal of Personalized Medicine,
Journal Year:
2022,
Volume and Issue:
12(11), P. 1767 - 1767
Published: Oct. 26, 2022
The
COVID-19
pandemic
has
represented
a
new
form
of
traumatic
event,
affecting
the
general
population
worldwide
and
causing
severe
disruption
daily
routine.
A
urgent
concern
is
related
to
burden
associated
with
symptoms
that
persist
beyond
onset
infection,
so-called
long-COVID
syndrome.
present
paper
aims
to:
(1)
describe
most
frequent
psychiatric
reported
by
patients
affected
syndrome;
(2)
evaluate
methodological
discrepancies
among
available
studies;
(3)
inform
clinicians
policy-makers
on
possible
strategies
be
promoted
in
order
manage
consequences
Twenty-one
papers
have
been
included
review,
mostly
cross-sectional
or
cohort
design.
Significant
heterogeneity
syndrome
definitions
was
found.
presence
evaluated
very
different
assessment
tools.
common
fatigue,
cognitive
disturbances/impairment,
depression,
anxiety
symptoms.
rate
fatigue
varied
from
93.2–82.3%
11.5%,
impairment/cognitive
dysfunction
61.4%
23.5%
depressive-anxiety
23.5%to
9.5%.
Infectious Disease Reports,
Journal Year:
2023,
Volume and Issue:
15(6), P. 806 - 830
Published: Dec. 15, 2023
The
coronavirus
disease
2019
(COVID-19),
instigated
by
the
zoonotic
Severe
Acute
Respiratory
Syndrome
Coronavirus
2
(SARS-CoV-2),
rapidly
transformed
from
an
outbreak
in
Wuhan,
China,
into
a
widespread
global
pandemic.
A
significant
post-infection
condition,
known
as
'long-
COVID-19'
(or
simply
COVID'),
emerges
substantial
subset
of
patients,
manifesting
with
constellation
over
200
reported
symptoms
that
span
multiple
organ
systems.
This
also
'post-acute
sequelae
SARS-CoV-2
infection'
(PASC),
presents
perplexing
clinical
picture
far-reaching
implications,
often
persisting
long
after
acute
phase.
While
initial
research
focused
on
immediate
pulmonary
impact
virus,
recognition
COVID-19
multiorgan
disruptor
has
unveiled
gamut
protracted
and
severe
health
issues.
review
summarizes
primary
effects
COVID
respiratory,
cardiovascular,
nervous
It
delves
mechanisms
underlying
these
impacts
underscores
critical
need
for
comprehensive
understanding
COVID's
pathogenesis.
Biomedicines,
Journal Year:
2024,
Volume and Issue:
12(4), P. 913 - 913
Published: April 20, 2024
Background:
Post-acute
sequelae
of
SARS-CoV-2
infection
(PASC)
is
a
complicated
disease
that
affects
millions
people
all
over
the
world.
Previous
studies
have
shown
PASC
impacts
10%
infected
patients
which
50–70%
are
hospitalised.
It
has
also
been
10–12%
those
vaccinated
against
COVID-19
were
affected
by
and
its
complications.
The
severity
later
development
symptoms
positively
associated
with
early
intensity
infection.
Results:
generated
health
complications
caused
involve
vast
variety
organ
systems.
Patients
diagnosed
neuropsychiatric
neurological
symptoms.
cardiovascular
system
involved
several
diseases
such
as
myocarditis,
pericarditis,
coronary
artery
reported.
Chronic
hematological
problems
thrombotic
endothelialitis
hypercoagulability
described
conditions
could
increase
risk
clotting
disorders
coagulopathy
in
patients.
Chest
pain,
breathlessness,
cough
respiratory
long-COVID
causing
distress
syndrome.
observed
immune
notable,
involving
diseases.
renal
was
impacted,
resulted
raising
issues,
fibrosis,
sepsis.
Endocrine
gland
malfunction
can
lead
to
diabetes,
thyroiditis,
male
infertility.
Symptoms
diarrhea,
nausea,
loss
appetite,
taste
among
reported
observations
due
gastrointestinal
disorders.
Skin
abnormalities
might
be
an
indication
long-term
implications
persistent
cutaneous
complaints
linked
PASC.
Conclusions:
Long-COVID
multidimensional
syndrome
considerable
public
implications,
affecting
physiological
systems
demanding
thorough
medical
therapy,
more
study
address
underlying
causes
effects
needed.
Medical Review,
Journal Year:
2024,
Volume and Issue:
5(1), P. 66 - 75
Published: July 1, 2024
Long
COVID,
as
currently
defined
by
the
World
Health
Organization
(WHO)
and
other
authorities,
is
a
symptomatic
condition
that
has
been
shown
to
affect
an
estimated
10
%-30
%
of
non-hospitalized
patients
after
one
infection.
However,
COVID-19
can
also
cause
organ
damage
in
individuals
without
symptoms,
who
would
not
fall
under
current
definition
COVID.
This
damage,
whether
or
not,
lead
various
health
impacts
such
heart
attacks
strokes.
Given
these
observations,
it
necessary
either
expand
COVID
include
recognize
COVID-19-induced
distinct
affecting
many
asymptomatic
infections.
It
important
consider
known
adverse
outcomes,
including
conditions
cancers,
be
until
harm
thresholds
are
reached.
Many
more
medical
identified
testing
than
those
recognized
through
reported
symptoms.
therefore
similarly
while
symptoms
associated
with
there
have
displaying
this
characterization
monitoring